Growth Strategy

Acquisition and In-Licensing of Products
Atrium Innovations' business and product development team focuses primarily on acquiring and in-licensing products. We work closely with our customers' research and development teams to identify specific market opportunities. Supported by an international network of consultants, our development team seeks technologies which complement our existing portfolio, answer unmet customer needs and help us establish relationships with new customers in new territories. Our knowledge of industry needs and regulatory requirements enables us to focus only on those scientific protocols needed to obtain regulatory approval and market acceptance. This allows us to reduce development costs and generally introduce acquired or in-licensed products in less than a year.

Internal Product Development
Atrium Innovations' internal product development team concentrates on product adaptations and improvements. Our team works on finding new applications or new formulations with existing active ingredients.

Collaboration with Research-Based Organizations
Our long-term product pipeline strategy is to partner with research and development organizations. In addition to in-licensing, we expect those partnerships to provide us with a solid pipeline of innovative products in the long term. Atrium Innovations invested in Océanova, an independent research organization dedicated to screening and developing clinically proven raw material ingredients for dietary supplement applications.

Company Acquisitions
Atrium Innovations' business development plan also includes a program for company acquisitions. The key features of the acquisition program are as follows:

• acquisition of nutritional supplement products or companies;
• acquisition of companies specializing in the manufacturing of active ingredients and specialty products.